Aging is accompanied by declining function and remodeling of body systems. In particular, changes to the immune and endocrine systems have far-reaching effects that cause an increase in cytokine release and decrease in anti-inflammatory feedback systems. The chronic inflammation that ensues has been named ‘‘inflammaging.’’ Inflammaging is associated with many detrimental effects that combine to increase morbidity and mortality. The sickness behavior that arises from inflammatory processes and the side effects of chronic diseases lead to a constellation of symptoms that decrease quality of life and affect the well-being of the individual. Part 2 of this two-part article provides an overview of the health effects of inflammaging, addressing the extent to which it contributes to the syndromes of frailty and disability with aging.
Alesci, S., Martinez, P.E., Kelkar, S., Ilias, I., Ronsaville, D.S., Listwak, S.J., et al. (2005). Major depression is associated with significant diurnal elevations in plasma IL-6 levels, a shift of its circadian rhythm, and loss of physiologic complexity in its secretion: Clinical implications . Biological Psychiatry, 57, 124S.
2.
Atkinson, H.H., Cesari, M., Kritchevsky, S.B., Penninx, B.W.J.H., Fried, L.P., Guralnik, J.M., et al. (2005). Predictors of combined cognitive and physical decline. Journal of the American Geriatrics Society, 53, 1197-1202.
3.
Bauer, J., & Sieber, C.C. ( 2008). Sarcopenia and frailty: a clinician’s controversial point of view. Experimental Gerontology, 43, 674-678.
4.
Baumgartner, R.N., Wayne, S.J., Waters, D.L., Janssen, I., Gallagher, D., & Morley, J.E. ( 2004). Sarcopenic obesity predicts Instrumental Activities of Daily Living disability in the elderly. Obesity Research, 12, 1995-2004.
5.
Bischoff-Ferrari, H.A., & Dawson-Hughes, B. (2007). Where do we stand on vitamin D? Bone, 41, S13-S19.
6.
Blaum, C.S., Li Xue, Q., Michelon, E., Semba, R.D., & Fried, L.P. ( 2005). The association between obesity and the frailty syndrome in older women: The Women’s Health and Aging Studies. Journal American Geriatrics Society, 53, 927-934.
7.
Brink, T.L., Yesavage, J.A., & Lum, O. ( 1982). Screening tests for geriatric depression. Clinical Gerontology, 1, 37-43.
8.
Bruunsgaard, H., Andersen-Ranberg, K., Hjelmborg, J.V.B., Pedersen, B.K., & Jeune, B. ( 2003). Elevated levels of tumor necrosis factor alpha and mortality in centenarians. American Journal of Medicine, 115, 278-283.
9.
Cesari, M., Penninx, B.W.J.H., Lauretani, F., Russo, C.R., Carter, C., Bandinelli, S., et al. (2004). Hemoglobin levels and skeletal muscle: Results from the InCHIANTI study. Journals of Gerontology Series A-Biological Sciences and Medical Sciences, 59, 249-254.
10.
Cesari, M., Penninx, B.W.J.H., Pahor, M., Lauretani, F., Corsi, A.M., Williams, G.R., et al. (2004). Inflammatory markers and physical performance in older persons: The InCHIANTI study. Journals of Gerontology Series A-Biological Sciences and Medical Sciences, 59, 242-248.
11.
Chaves, P., Ashar, B., Guralnik, J.M., & Fried, L.P. ( 2002). Looking at the relationship between hemoglobin concentration and prevalent mobility difficulty in older women. Should the criteria currently used to define anemia in older people be reevaluated? Journal of the American Geriatrics Society, 50, 1257-1264.
12.
Ciftci, T.U., Kokturk, O., Bukan, N., & Bilgihan, A. ( 2004). The relationship between serum cytokine levels with obesity and obstructive sleep apnea syndrome. Cytokine, 28, 87-91.
13.
Corish, C.A., & Kennedy, N.P. ( 2003). Anthropometric measurements from a cross-sectional survey of Irish free-living elderly subjects with smoothed centile curves. British Journal of Nutrition, 89, 137-145.
14.
Corwin, E.J. ( 2000b). Understanding cytokines Part II: Implications for nursing research and practice. Biological Research for Nursing, 2, 41-48.
15.
Dantzer, R. ( 2001). Cytokine-induced sickness behavior: Where do we stand ? Brain Behavior and Immunity, 15, 7-24.
16.
Department of Health (2006). National Service Framework for older people: Standard 6 - Falls. London: HMSO.
17.
Eisenstaedt, R., Penninx, B.W.J. H., & Woodman, R.C. ( 2006). Anemia in the elderly: Current understanding and emerging concepts. Blood Reviews, 20, 213-226.
18.
Ershler, W.B. ( 2003). Biological interactions of aging and anemia: A focus on cytokines. Journal of the American Geriatrics Society, 51, S18-S21.
19.
Ershler, W.B., & Keller, E.T. ( 2000). Age-associated increased interleukin-6 gene expression, late-life diseases, and frailty. Annual Review of Medicine , 51, 245-270.
20.
Ferrucci, L., Cavazzini, C., Corsi, A., Bartali, B., Russo, C.R., Lauretani, F., et al. (2002a). Biomarkers of frailty in older persons . Journal of Endocrinological Investigation, 25, 10-15.
21.
Ferrucci, L., Penninx, B.W.J.H., Volpato, S., Harris, T.B., Bandeen-Roche, K., Balfour, J., et al. (2002). Change in muscle strength explains accelerated decline of physical function in older women with high interleukin-6 serum levels. Journal of the American Geriatrics Society, 50, 1947-1954.
22.
Fitzsimons, E.J., & Brock, J.H. ( 2001). The anemia of chronic disease-Remains hard to distinguish from iron deficiency anemia in some cases. British Medical Journal, 322, 811-812.
23.
Flicker, L., Mead, K., MacInnis, R.J., Nowson, C., Scherer, S., Stein, M.S., et al. (2003). Serum vitamin D ain older women in residential care in Australia. Journal of the American Geriatrics Society , 51, 1533-1538.
24.
Flicker, L. ( 2008). Should geriatric medicine remain a specialty? British Medical Journal, 337, 78-79.
25.
Franceschi, C., Bonafe, M., Valensin, S., Olivieri, F., De Luca, M., Ottaviani, E., et al. (2000). Inflamm-aging-An evolutionary perspective on immunosenescence. Molecular and Cellular Gerontology, 908, 244-254.
26.
Franceschi, C., Capri, M., Monti, D., Giunta, S., Olivieri, F., Sevini, F., et al. (2007). Inflammaging and anti-inflammaging: A systemic perspective on aging and longevity emerged from studies in humans. Mechanisms of Aging and Development, 128, 92-105.
27.
Fried, L.P., Darer, J., & Walston, J. ( 2002). Frailty. In C. K. Cassel et al. (Eds.), Geriatric medicine: An evidence-based approach (4th ed., pp. 1067-1076). New York: Sringer-Verlag.
28.
Fried, L.P., & Walston, J. ( 2003). Frailty and failure to thrive. In W. R. Hazzard et al. (Eds.), Principles of geriatric medicine and gerontology (5th ed., pp. 1487-1502). New York: McGraw-Hill.
29.
Grabowski, D.C., Campbell, C.M., & Ellis, J.E. ( 2005). Obesity and mortality in elderly nursing home residents . Journals of Gerontology Series A-Biological Sciences and Medical Sciences, 60, 1184-1189.
30.
Harris, T., Cook, D.G., Victor, C., DeWilde, S., & Beighton, C. ( 2006). Onset and persistence of depression in older people- results from a 2-year community follow-up study. Age and Ageing , 35, 25-32.
31.
Hong, S., Mills, P.J., Loredo, J.S., Adler, K.A., & Dimsdale, J.E. (2005). The association between interleukin-6, sleep, and demographic characteristics. Brain Behavior and Immunity, 19, 165-172.
32.
Irwin, M. ( 2002). Effects of sleep and sleep loss on immunity and cytokines . Brain Behavior and Immunity, 16, 503-512.
33.
Johnson, B.E. ( 2004). Review: prophylactic use of vitamin D reduces falls in older persons. Evidence-Based Medicine, 9, 169.
34.
Kop, W.J., Gottdiener, J.S., Tangen, C.M., Fried, L.P., McBurnie, M.A., Walston, J., et al. (2002). Inflammation and coagulation factors in persons > 65 years of age with symptoms of depression but without evidence of myocardial ischemia. American Journal of Cardiology, 89, 419-424.
35.
Kotler, D.P. ( 2000). Cachexia. Annals of Internal Medicine , 133, 622-634.
36.
Krabbe, K.S., Pedersen, M., & Bruunsgaard, H. (2004). Inflammatory mediators in the elderly. Experimental Gerontology, 39, 687-699.
37.
Leineweber, C., Kecklund, G., Janszky, I., Akerstedt, T., & Orth-Gomer, K. (2003). Poor sleep increases the prospective risk for recurrent events in middle-aged women with coronary disease- The Stockholm Female Coronary Risk Study. Journal of Psychosomatic Research, 54, 121-127.
38.
Leonard, B.E. ( 2001). The immune system, depression and the action of anti-depressants . Progress in Neuro-Psychopharmacology and Biological Psychiatry , 25, 767-780.
39.
Licastro, F., Candore, G., Lio, D., Porcellini, E., Colonna-Romano, G., Franceschi, C., et al. (2005). Innate immunity and inflammation in aging: A key for understanding age-related diseases. Immunity and Aging, 2, 1-14.
40.
Liukkonen, T., Silvennoinen-Kassinen, S., Jokelainen, J., Rasanen, P., Leinonen, M., Meyer-Rochow, V.B., et al. (2006). The association between C-reactive protein levels and depression: Results from the Northern Finland 1966 Birth Cohort study. Biological Psychiatry, 60, 825-830.
41.
Maes, M., Bosmans, E., DeJongh, R., Kenis, G., Vandoolaeghe, E., & Neels, H. ( 1997). Increased serum IL-6 and IL-1 receptor antagonist concentrations in major depression and treatment resistant depression. Cytokine , 9, 853-858.
42.
Manolagas, S.C., & Jilka, R.L. ( 1995). Mechanisms of disease- bone-marrow, cytokines, and bone remodeling-emerging insights into the pathophysiology of osteoporosis. New England Journal of Medicine, 332, 305-311.
43.
Martinez, M., Hernanz, A., Gomezcerezo, J., Pena, J.M., Vazquez, J.J., & Arnalich, F. ( 1993). Alterations in plasma and cerebrospinal-fluid levels of neuropeptides in idiopathic senile anorexia. Regulatory Peptides, 49, 109-117.
44.
McDougall, F.A., Matthews, F.E., Kvaal, K., Dewey, M.E., & Brayne, C. ( 2007). Prevalence and symptomatology of depression in older people living in institutions in England and Wales. Age and Ageing, 36, 562-568.
45.
Meier-Ewert, H.K., Ridker, P.M., Rifai, N., Regan, M.M., Price, N.J., & Dinges, D.F. et al. (2004). Effect of sleep loss on C-reactive protein, an inflammatory marker of cardiovascular risk. Journal of the American College of Cardiology, 43, 678-683.
46.
Mitch, W.E., & Goldberg, A.L. (1996). Mechanisms of disease: Mechanisms of muscle wasting-The role of the ubiquitinproteasome pathway. New England Journal of Medicine, 335, 1897-1905.
47.
Moldawer, L.L. & Copeland, E.M.1997, ‘‘Proinflammatory cytokines, nutritional support, and the cachexia syndrome-Interactions and therapeutic options’’ , Cancer, vol. 79, no. 9, pp. 1828-1839.
Morley, J.E., Mitchell Perry III, H., & Miller, D.K.2002, ‘‘Something about Frailty’’. Journal of Gerontology: MEDICAL SCIENCES vol. 57A, no.11, pp. M698-M704.
50.
Morley, J.E., & Baumgartner, R.N. (2004). Cytokine-related aging process. Journals of Gerontology Series A-Biological Sciences and Medical Sciences, 59, 924-929.
51.
Morley, J.E., Baumgartner, R.N., Roubenoff, R., Mayer, J., & Nair, K.S. ( 2001). Sarcopenia. Journal of Laboratory and Clinical Medicine, 137, 231-243.
52.
Myint, A.M., & Kim, Y.K. ( 2003). Cytokine-serotonin interaction through IDO: a neurodegeneration hypothesis of depression. Medical Hypotheses, 61, 519-525.
53.
Newman, A.B., Haggerty, C.L., Goodpaster, B., Harris, T., Kritchevsky, S., Nevitt, M., et al. (2003). Strength and muscle quality in a well-functioning cohort of older adults: The Health, Aging and Body Composition Study. Journal of the American Geriatrics Society, 51, 323-330.
54.
Nilsson-Ehle, H., Jagenburg, R., Landahl, S., & Svanborg, L. ( 2000). Blood haemoglobin declines in the elderly: Implications for reference intervals from age 70 to 88. European Journal of Haematology, 65, 297-305.
55.
Papanicolaou, D.A., & Vgontzas, A.N. (2000). Editorial: Interleukin-6: The endocrine cytokine. Journal of Clinical Endocrinology and Metabolism, 85, 1331-1333.
56.
Penninx, B.W., Kritchevsky, S.B., Newman, A.B., Nicklas, B.J., Simonsick, E.M., Rubin, S., et al. (2004). Inflammatory markers and incident mobility limitation in the elderly. Journal of the American Geriatrics Society, 52, 1105-1113.
57.
Penninx, B.W., Pahor, M., Cesari, M., Corsi, A.M., Woodman, R.C., Bandinelli, S., et al. (2004). Anemia is associated with disability and decreased physical performance and muscle strength in the elderly. Journal of the American Geriatrics Society, 52, 719-724.
58.
Perez-Lopez, F.R. ( 2007). Vitamin D and its implications for musculoskeletal health in women: An update. Maturitas, 58, 117-137.
59.
Prinz, P.N. ( 2004). Age impairments in sleep, metabolic and immune functions . Experimental Gerontology, 39, 1739-1743.
60.
Puts, M.T.E., Lips, P., & Deeg, D.J.H. ( 2005). Static and dynamic measures of frailty predicted decline in performance-based and self-reported physical functioning. Journal of Clinical Epidemiology, 58, 1188-1198.
61.
Raison, C.L., Capuron, L., & Miller, A.H. ( 2006). Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends in Immunology, 27, 24-31.
62.
Robertson, R.G., & Montagnini, M. (2004). Geriatric failure to thrive . American Family Physician, 70, 343-350.
63.
Rockwood, K. ( 2005). Frailty and its definition: A worthy challenge. Journal American Geriatrics Society, 53, 1069-1070.
64.
Rodman, J.S., & Baker, T. ( 1978). Changes in kinetics of muscle-contraction in vitamin-D-depleted rats. Kidney International, 13, 189-193.
Schalk, B.W.M., Visser, M., Deeg, D.J.H., & Bouter, L.M. ( 2004). Lower levels of serum albumin and total cholesterol and future decline in functional performance in older persons: the Longitudinal Aging Study Amsterdam. Age and Ageing, 33, 266-272.
67.
Stein, M.S., Wark, J.D., Scherer, S.C., Walton, S.L., Chick, P., Di Carlantonio, M., et al. (1999). Falls relate to vitamin D and parathyroid hormone in an Australian nursing home and hostel. Journal of the American Geriatrics Society, 47, 1195-1201.
68.
Stein, M.S., Flicker, L., Scherer, S.C., Paton, L.M., O’Brien, M.L., Walton, S.C., et al. (2001). Relationships with serum parathyroid hormone in old institutionalized subjects. Clinical Endocrinology , 54, 583-592.
69.
Stek, M.L., Vinkers, D.J., Gussekloo, J., Beekman, A.T.F., van der Mast, R.C., & Westendorp, R.G.J. (2005). Is depression in old age fatal only when people feel lonely?American Journal of Psychiatry , 162, 178-180.
70.
Studenski, S., Hayes, R.P., Leibowitz, R.Q., Bode, R., Lavery, L., Walston, J., et al. (2004). Clinical global impression of change in physical frailty: Development of a measure based on clinical judgment. Journal of the American Geriatrics Society, 52, 1560-1566.
71.
Sullivan, D.H., Liu, L., Roberson, P.K., Bopp, M.M., & Rees, J.C. ( 2004). Body weight change and mortality in a cohort of elderly patients recently discharged from the hospital. Journal of the American Geriatrics Society, 52, 1696-1701.
72.
van Exel, E., de Craen, A.J.M., Remarque, E.J., Gussekloo, J., Houx, P., Bootsma-van der Wiel, A., et al. (2003). Interaction of atherosclerosis and inflammation in elderly subjects with poor cognitive function. Neurology , 61, 1695-1701.
73.
Vasto, S., Candore, G., Balistreri, C.R., Caruso, M., Colonna-Romano, G., Grimaldi, M.P., et al. (2007). Inflammatory networks in aging, age-related diseases and longevity. Mechanisms of Aging and Development , 128, 83-91.
74.
Vellas, B., Gillette-Guyonnet, S., Nourhashemi, F., Rolland, Y., Lauque, S., Ousset, P.J., et al. (2000). Falls, frailty and osteoporosis in the elderly. Revue de Medecine Interne, 21, 608-613.
75.
Visser, M., Kritchevsky, S.B., Newman, A.B., Goodpaster, B.H., Tylavsky, F.A., Nevitt, M.C., et al. (2005). Lower serum albumin concentration and change in muscle mass: The Health, Aging and Body Composition Study. American Journal of Clinical Nutrition, 82, 531-537.
76.
Visser, M., Langlois, J., Guralnik, J.M., Cauley, J.A., Kronmal, R.A., Robbins, J., et al. (1998). High body fatness, but not low fat-free mass, predicts disability in older men and women: The Cardiovascular Health Study. American Journal of Clinical Nutrition, 68, 584-590.
77.
Visser, M., Pahor, M., Taaffe, D.R., Goodpaster, B.H., Simonsick, E.M., Newman, A.B., et al. (2002). Relationship of Interleukin-6 and tumour necrosis factor- with muscle mass and muscle strength in elderly men and women: The Health ABC Study. Journal of Gerontology, 57, 326-332.
78.
Visser, M., Deeg, D.J.H., & Lips, P.2003, ‘‘Low vitamin D and high parathyroid hormone levels as determinants of loss of muscle strength and muscle mass (Sarcopenia): The Longitudinal Aging Study Amsterdam’’, Journal of Clinical Endocrinology and Metabolism, vol. 88, no. 12, pp. 5766-5772.
79.
Volpato, S., Leveille, S.G., Corti, M.C., Harris, T.B., & Guralnik, J.M. (2001). The value of serum albumin and high-density lipoprotein cholesterol in defining mortality risk in older persons with low serum cholesterol. Journal of the American Geriatrics Society, 49, 1142-1147.
80.
Walston, J., McBurnie, M.A., Newman, A., Tracy, R.P., Kop, W.J., Hirsch, C.H., et al. (2002). Frailty and activation of the inflammation and coagulation systems with and without clinical comorbidities - Results from the Cardiovascular Health Study. Archives of Internal Medicine, 162, 2333-2341.
81.
Watkins, L.R., Nguyen, K.T., Lee, J.R., & Maier, S.F. ( 1999). Dynamic regulation of proinflammatory cytokines. Advances in Experimental Medicine and Biology, 461, 153-178.
82.
Weiss, G. ( 2002). Pathogenesis and treatment of anemia of chronic disease . Blood Reviews, 16, 87-96.
83.
Whooley, M.A., Kip, K.E., Cauley, J.A., Ensrud, K.E., Nevitt, M.C., & Browner, W.S. ( 1999). Depression, falls and risk of fracture in older women . Archives of Internal Medicine, 159, 484-490.
84.
Woods, N.F., LaCroix, A.Z., Gray, S.L., Aragaki, A., Cochrane, B.B., Brunner, R.L., et al. (2005). Frailty: Emergence and consequences in women aged 65 and older in the women’s health initiative observational study. Journal of the American Geriatrics Society, 53, 1321-1330.
85.
Zamboni, M., Mazzali, G., Fantin, F., Rossi, A., & Di Francesco, V. (2008). Sarcopenic obesity: A new category of obesity in the elderly. Nutrition, Metabolism and Cardiovascular Diseases, 18, 388-395.
86.
Zuccala, G., Pedone, C., Cesari, M., Onder, G., Pahor, M., Marzetti, E., et al. (2003). The effects of cognitive impairment on mortality among hospitalized patients with heart failure. American Journal of Medicine, 115, 97-103.
